Arthur Weiss, M.D., Ph.D.
Art is the Ephraim P. Engleman Distinguished Professor of Rheumatology in the Department of Medicine at the University of California San Francisco, where he has been on the faculty since 1985. He served as Division Chief of Rheumatology at UCSF from 1988-2011. He has been an Investigator of the Howard Hughes Medical Institute since 1985. Art is a leading researcher in the field of signal transduction in the immune system, focusing on the roles of tyrosine kinases and phosphatases in regulating lymphocyte activation. He has studied how abnormalities in tyrosine phosphorylation pathways can lead to immunologically-mediated diseases.
Art is a member of the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences. He is a receipient of the Distinguished Investigator Award of the ACR, Arthritis Foundation’s Lee C. Howley Prize, and the American Association of Immunologists Meritorious Career Award.
Art is a co-founder of Nurix, Inc. and is on the Scientific Advisory/Review Boards of Five Prime Therapeutics, Genentech, Molecular Stethoscope, and Portola Pharmaceuticals.